Paulami Guha
Obstetrics & Gynecology · Jacksonville, FLNPI 1912260613
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Bayer at 28.7% of the total. 2025 is the largest year on record at $2,083, 2.7 times the $780 reported in 2019. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $42.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$2K
- Acessa Health Inc.$994
- AbbVie$538
- Hologic Sales And Service, LLC$230
- Intuitive Surgical$210
- Astellas Pharma US Inc$209
- plus $2K from 32 others
What the payments were for
- Speaking & faculty fees$1,60026%
- Travel & lodging$86714%
- Food & beverage$3,54858%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 8 | $1,753 |
| Acessa Health Inc. | 6 | $994 |
| AbbVie(2 entities) | 23 | $538 |
| Hologic Sales And Service, LLC | 7 | $230 |
| Intuitive Surgical | 2 | $210 |
| Astellas Pharma US Inc | 7 | $209 |
| Novo Nordisk | 5 | $208 |
| Pfizer | 9 | $167 |
| Mayne Pharma Commercial LLC | 6 | $159 |
| Myovant Sciences Inc. | 11 | $153 |
| Shield Therapeutics Inc | 4 | $151 |
| Lupin Inc. | 3 | $150 |
| Millicent US Inc | 8 | $136 |
| Exeltis, USA Inc. | 7 | $110 |
| Aspira Women's Health Inc | 1 | $107 |
| Sumitomo Pharma America, Inc. | 4 | $95 |
| Daiichi Sankyo Inc. | 5 | $87 |
| Mycovia Pharmaceuticals, Inc. | 2 | $50 |
| Merck | 2 | $47 |
| Therapeuticsmd, Inc. | 3 | $44 |
| Applied Medical Resources Corporation | 1 | $43 |
| Evofem Biosciences, Inc. | 2 | $42 |
| Scynexis, Inc. | 3 | $41 |
| Aesculap, Inc. | 1 | $40 |
| Mallinckrodt Enterprises LLC | 1 | $38 |
| Olympus America Inc. | 1 | $36 |
| Covidien LP | 1 | $34 |
| LSI Solutions Inc | 1 | $29 |
| Coopersurgical, Inc. | 1 | $28 |
| Dysis Medical, Inc. | 2 | $26 |
| Channel Medsystems, Inc. | 1 | $25 |
| Organon | 1 | $20 |
| Duchesnay USA Incorporated | 1 | $19 |
| Roche Diagnostics Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Avion Pharmaceuticals | 1 | $15 |
| Asensus Surgical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lynkuet$1,600
- ACESSA PROVU SYSTEM$876
- Da Vinci Surgical System$133
- SOLOSEC$125
- Saxenda$125
- Orilissa$123
- ORIAHNN$123
- OVA1$107
How this compares
$6,100 in reported general payments places this provider in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 29 | $12,497 |
| Estradiol | 81 | $8,499 |
| Clobetasol Propionate | 33 | $1,867 |
| Metronidazole | 24 | $816 |
| Fluconazole | 41 | $251 |
| Misoprostol | 13 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $167 | $12,49729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Jacksonville
- David MillerJacksonville$26K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.